Essa Pharma (EPIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2014 | 09-2008 | 09-2007 | 09-2006 | 09-2005 | |
| Sales | 0 | 28,628 | 14,960 | 6,041 | 7,190 |
| Gross Profit | N/A | 28,628 | 14,960 | 6,041 | 7,190 |
| Operating Expenses | 1,825 | 16,628 | 20,997 | 13,954 | 10,656 |
| Operating Income | -1,825 | 12,001 | -6,037 | -7,913 | -3,466 |
| Interest Expense | 0 | 3,785 | 4,068 | 5,076 | 3,613 |
| Other Income | 1 | -44,887 | -52,626 | -144,259 | -14,147 |
| Pre-tax Income | -1,824 | -36,671 | -62,731 | -157,248 | -21,227 |
| Income Tax | N/A | N/A | 58 | 145 | 42 |
| Net Income Continuous | -1,824 | -36,671 | -62,789 | -157,393 | -21,269 |
| Net Income | $-1,824 | $-36,671 | $-62,789 | $-157,393 | $-21,269 |
| EPS Basic Total Ops | -2.40 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -2.33 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -2.40 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -2.33 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,801 | $12,001 | $-6,037 | $-7,913 | $-3,466 |